Genmab and Incyte have announced a clinical trial collaboration to evaluate a new combination treatment for patients with first-line KRAS…
Browsing: Clinical Updates
Wearable devices are gaining interest in gastroenterology as tools for monitoring disease activity between clinical visits, particularly in inflammatory bowel…
Dartmouth’s RADIUS telemedicine program is using gastroenterology advanced practice providers (APPs) to extend specialized inflammatory bowel disease (IBD) care to…
A UK-wide analysis of nearly 16,000 IBD surveillance endoscopies performed in 2024 has identified opportunities to improve colorectal cancer detection…
The FDA has expanded its approval of risankizumab (Skyrizi) to include a subcutaneous induction regimen for adults with moderately to…
A multinational study published in Clinical Gastroenterology and Hepatology found that abdominal pain in irritable bowel syndrome (IBS) is closely…
Takeda announced positive results from VERDICT, a Phase 4 randomized trial evaluating treat-to-target strategies with vedolizumab (Entyvio) in adults with…
An updated version of Freenome’s SimpleScreen colorectal cancer (CRC) blood test demonstrated improved sensitivity for detecting advanced precancerous lesions (APLs),…
Geneoscopy has launched ColoSense NextStep, an opt-in patient navigation program designed to help patients with positive results from its ColoSense…
The updated STRIDE-III recommendations refine the international treat-to-target framework for Crohn’s disease and ulcerative colitis, incorporating new evidence on inflammatory…